Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies

25 Jan 2022

Abstract excerpt

Multiple studies have investigated the role of blood circulating proteins in COVID-19 disease using the Olink affinity proteomics platform. However, study inclusion criteria and sample collection conditions varied between studies, leading to sometimes incongruent associations. To identify the most robust protein markers of the disease and the underlying pathways that are relevant under all conditions, it is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Inflammasome and immune disorders
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35145507
DOI: 10.3389/fimmu.2021.781100

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical StudiesPMID 35145507Read ↗

Circulating proteins to predict adverse COVID-19 outcomesSemantic proximity Read ↗

Proteomic blood profiling in mild, severe and critical COVID-19 patientsSemantic proximity Read ↗

COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data modelSemantic proximity Read ↗

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients.Semantic proximity Read ↗

Comparative Analysis Between Olink‐PEA and Alamar‐NULISA Proteomic Technologies Applied to a Critically Ill COVID‐19 CohortSemantic proximity Read ↗

Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19Semantic proximity Read ↗

Inflammation Patterns in Omicron Variant-Linked COVID-19: Assessing Biomarkers for Predicting Disease SeveritySemantic proximity Read ↗

Computational Profiling of Inflammatory and Coagulation Responses in COVID-19 via RNA-SeqSemantic proximity Read ↗

Large-scale Multi-omic Analysis of COVID-19 SeveritySemantic proximity Read ↗

Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19Semantic proximity Read ↗

High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversionSemantic proximity Read ↗

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.